Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Rite Aid Corp (RAD)

Rite Aid Corp (RAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 36,756
  • Shares Outstanding, K 56,696
  • Annual Sales, $ 24,092 M
  • Annual Income, $ -749,940 K
  • 60-Month Beta 1.25
  • Price/Sales 0.00
  • Price/Cash Flow 0.36
  • Price/Book N/A
Trade RAD with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.74
  • Most Recent Earnings $-0.73 on 06/29/23
  • Latest Earnings Date 10/19/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend 0.115 on 10/14/99
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 181.67%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Sell
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 08/31/23
See More
  • Average Estimate -1.35
  • Number of Estimates 3
  • High Estimate -0.72
  • Low Estimate -1.96
  • Prior Year -0.63
  • Growth Rate Est. (year over year) -114.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3779 +61.97%
on 09/25/23
0.9599 -36.23%
on 10/11/23
-0.0557 (-8.34%)
since 09/15/23
3-Month
0.3779 +61.97%
on 09/25/23
3.1600 -80.63%
on 08/04/23
-0.9279 (-60.25%)
since 07/14/23
52-Week
0.3779 +61.97%
on 09/25/23
7.3700 -91.69%
on 11/15/22
-3.2479 (-84.14%)
since 10/14/22

Most Recent Stories

More News
Rite Aid banned from facial recognition tech use for 5 years after faulty theft targeting in stores

Rite Aid has been banned from using facial recognition technology for five years over allegations that a surveillance system it used incorrectly identified potential shoplifters, especially Black, Latino,...

RAD : 0.6483 (-16.81%)
$SPX : 5,149.42 (+0.63%)
$DOWI : 38,790.43 (+0.20%)
$IUXX : 17,985.01 (+0.99%)
Rite Aid seeks Chapter 11 bankruptcy protection as it deals with lawsuits and losses

Rite Aid has filed for bankruptcy and plans to sell part of its business as it attempts to restructure while dealing with losses and opioid-related lawsuits

$SPX : 5,149.42 (+0.63%)
$DOWI : 38,790.43 (+0.20%)
$IUXX : 17,985.01 (+0.99%)
AMZN : 174.48 (+0.03%)
RAD : 0.6483 (-16.81%)
Why Shares of Rite Aid Soared This Week

The drugstore company may be benefiting from a short squeeze.

RAD : 0.6483 (-16.81%)
Rite Aid (RAD) Q1 2024 Earnings Call Transcript

RAD earnings call for the period ending March 31, 2023.

RAD : 0.6483 (-16.81%)
Time Warp: Walgreens Stock Travels Back in Time to 2010

Integrated healthcare and pharmacy retailer Walgreens Boots Alliance Inc. (NYSE: WBA) stock fell 21.75% year-to-date (YTD). Learn more about Walgreens shares.

WBA : 20.69 (-0.62%)
WMT : 60.86 (+0.30%)
RAD : 0.6483 (-16.81%)
CVS : 77.57 (+0.22%)
DB : 14.63 (-1.28%)
LEA : 140.41 (+0.16%)
MS : 87.96 (-0.48%)
POST : 104.39 (+0.89%)
MarketBeat Week in Review – 6/26 - 6/30

Markets headed into a holiday week cheering a lower-than-expected key inflation reading, but investors should expect volatility in a short trading week.

NIO : 5.54 (-0.72%)
FROG : 43.11 (+2.16%)
MLTX : 48.56 (+2.77%)
MDB : 356.37 (+0.26%)
SHW : 335.27 (+0.18%)
GIS : 67.74 (+1.47%)
MULN : 5.16 (-6.18%)
AAPL : 173.72 (+0.64%)
GOOGL : 147.68 (+4.60%)
LCID : 2.75 (+1.85%)
KFY : 64.16 (+1.12%)
META : 496.98 (+2.66%)
Rite Aid Could Become An Acquisition Target

Rite Aid may be on its last leg, hoping for these catalysts to be realized may offer investors one last chance at a turnaround. Analysts are considering it too

RAD : 0.6483 (-16.81%)
Rite Aid: Fiscal Q1 Earnings Snapshot

Rite Aid: Fiscal Q1 Earnings Snapshot

RAD : 0.6483 (-16.81%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rite Aid Corporation - RAD

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Rite Aid Corporation ("Rite Aid" or the "Company") (NYSE: RAD). Such investors...

RAD : 0.6483 (-16.81%)
RAD SHAREHOLDER ALERT: Jakubowitz Law Reminds Rite Aid Shareholders of a Lead Plaintiff Deadline of May 19, 2023

/PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Rite Aid Corporation (NYSE:...

RAD : 0.6483 (-16.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Rite Aid Corporation is on the front lines of delivering health care services and retail products to over one million Americans daily. It provides an array of whole being health products and services for the entire family through retail pharmacies across states. Through Elixir, pharmacy benefits manager,...

See More

Key Turning Points

3rd Resistance Point 0.9055
2nd Resistance Point 0.8528
1st Resistance Point 0.7505
Last Price 0.6483
1st Support Level 0.5955
2nd Support Level 0.5428
3rd Support Level 0.4405

See More

52-Week High 7.3700
Fibonacci 61.8% 4.6990
Fibonacci 50% 3.8740
Fibonacci 38.2% 3.0489
Last Price 0.6483
52-Week Low 0.3779

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar